Completed Infection & Immunity

Centre for Neglected Tropical Diseases Drug Discovery

In plain English

AI plain-English summary

Neglected tropical diseases like visceral leishmaniasis and Chagas' disease kill or disable hundreds of thousands of people each year, yet almost no one develops new drugs to treat them. This Wellcome Trust Centre will act as a dedicated hub where academic researchers, pharmaceutical companies, and product development partnerships collaborate to turn fundamental discoveries into actual drug candidates. The problem is stark: market incentives do not exist for these diseases, so the drug pipeline is nearly empty. The Centre aims to fix that by accelerating the delivery of drug candidates, improving how scientists predict whether a compound will work in the body, and developing better disease models that more accurately reflect human infection. It will also train scientists from affected countries, ensuring expertise spreads beyond Dundee. If successful, the Centre could produce new treatments for diseases that currently have few options, and change the paradigm for how neglected disease drug discovery is done globally—making it faster, more efficient, and more collaborative.

View original technical description
The vision for the Centre is to help tackle the urgent unmet medical need and lack of drug discovery research for Neglected Tropical Diseases (NTDs) by creating the hub for NTD drug discovery and being the collaborator of choice for academics, Pharma and Product Development Partnerships (PDPs) in the translation of discovery science into drug candidates. The success of this vision will be evidenced by increased integration, efficiency and effectiveness of the discovery science, drug discovery and mode-of-action teams in Dundee, providing: Accelerated delivery of NTD drug candidates for our PDP partners, with an initial focus on visceral leishmaniasis and Chagas' disease. Improved paradigms for carrying out NTD drug discovery, including improved understanding of PKPD relationships and more predictive disease models. Improved methodology to determine drug modes of action and resistance mechanisms. Increased exploitation of novel drug targets through structure based drug discovery, involving collaborators worldwide. Training and support for international scientists in the theory and practice of NTD drug discovery. Increased public engagement and awareness of the impact of, and need for, new medicines for NTDs and a greater understanding of the nature and importance of drug discovery.

View the original record at the funder ↗

Researchers

Paul Wyatt (EPMC Awardee)

Related Research

Grants with similar aims, by meaning.

A platform for drug target deconvolution and exploitation
A Global Network for Neglected Tropical Diseases
Global Network for NTDs
Development of a new preclinical candidate for Chagas disease
EPSRC Centre for Doctoral Training in Advanced Therapeutics & Nanomedicines

Original classification

Wellcome Trust Centre

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.